Patent ID: 11894141
Assignee: PROGENICS PHARMACEUTICALS, INC.
Field: Measurement (Instruments)
Classification: CPC G | IPC G

Claim 23:
24. A method comprising performing, by a processor of a server computing device, (i) to (iv) as follows:
(i) receiving and storing, by the processor of a server computing device, said processor a processor of a cloud-based system, a plurality of medical images in a database, each medical image associated with a particular corresponding patient;
(ii) accessing, by the processor, one or more of the medical images associated with a particular patient from the database;
(iii) automatically analyzing, by the processor, the one or more medical images using a machine learning algorithm; and
(iv) generating, by the processor, a radiologist report for the particular patient according to the one or more medical images for the patient,
wherein the one or more medical images comprise a composite image of the particular patient, the composite image comprising a CT scan overlaid with a nuclear medicine image acquired at a substantially same time as the CT scan and following administration to the patient of an imaging agent comprising a Prostate Specific Membrane Antigen (PSMA) binding agent comprising a radionuclide, wherein the method comprises automatically analyzing the composite image by:
(a) using the composite image to geographically identify a 3D boundary for each of one or more regions of imaged tissue within the nuclear medicine image; and
(b) computing, using the nuclear medicine image with the identified 3D boundary(ies) of the one or more region(s), a value of each of one or more risk indices, each risk index value indicative of cancer state or progression in the patient.